Utilization and Effectiveness of the CA 19-9 Test for Cancer Diagnosis: Insights from Health Ministry Records
Introduction:This retrospective study evaluated the use and findings of the CA 19-9 test in the diagnosis of pancreatic cancer.Methods:The study analyzed data from a large population of 2,981,142 individuals who underwent CA 19-9 testing between 2017 and 2021. The number of tests performed, test rat...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Galenos Yayinevi
2023-08-01
|
| Series: | İstanbul Medical Journal |
| Subjects: | |
| Online Access: |
http://istanbulmedicaljournal.org/archives/archive-detail/article-preview/utilization-and-effectiveness-of-the-ca-19-9-test-/61907
|
| Summary: | Introduction:This retrospective study evaluated the use and findings of the CA 19-9 test in the diagnosis of pancreatic cancer.Methods:The study analyzed data from a large population of 2,981,142 individuals who underwent CA 19-9 testing between 2017 and 2021. The number of tests performed, test rates per 100,000 population, and 25,808,137 test results were assessed. The study also investigated the association between CA 19-9 levels and cancer diagnoses.Results:The study found that CA 19-9 was a widely used tumor marker for pancreatic cancer diagnosis. However, it was noted that the test had limitations as a standalone diagnostic tool. In the analyzed population, the test results showed elevated CA 19-9 levels in more than 80% of patients diagnosed with pancreatic cancer. The study also observed variations in test use and outcomes across different age groups, genders and regions.Conclusion:Our findings highlight the significance of the CA 19-9 test in the diagnosis of pancreatic cancer. However, it is crucial to consider the limitations of using CA 19-9 as a standalone test and incorporate it into a comprehensive diagnostic approach involving other clinical and laboratory methods. Further multicenter and prospective studies are warranted to better understand the accuracy and effectiveness of the CA 19-9 test in pancreatic cancer diagnosis. |
|---|---|
| ISSN: | 2619-9793 2148-094X |